Search filters

List of works by Kristin Köhler-Forsberg

A chronic increase of corticosterone age-dependently reduces systemic DNA damage from oxidation in rats

scientific article published on 6 January 2017

Changes in Hippocampal Volume, 5-HT4 receptor binding, and Verbal Memory Over the Course of Antidepressant Treatment in Major Depressive Disorder

scientific article published in November 2024

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study

scientific article published on 11 July 2022

Dynamic regulation of cerebral DNA repair genes by psychological stress

scientific article published on 27 December 2014

EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm study

scientific article published in February 2024

Effect of antidepressant treatment on 5-HT4 receptor binding and associations with clinical outcomes and verbal memory in major depressive disorder

scientific article published in August 2024

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study

scientific article published on 8 November 2022

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol

scientific article published on 23 July 2020

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder

scientific article published on 05 June 2020

Psychoneuroendocrine profiles of unmedicated men with major depressive disorder and associations to treatment effects and sexual side-effects

Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study

scientific article published in January 2021

Stress hormone dynamics are coupled to brain serotonin 4 receptor availability in unmedicated patients with Major Depressive Disorder – a NeuroPharm study

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study

scientific article published on 11 March 2022